tradingkey.logo

QuidelOrtho Corp

QDEL
29.100USD
+0.410+1.43%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
1.98BMarktkapitalisierung
VerlustKGV TTM

QuidelOrtho Corp

29.100
+0.410+1.43%

mehr Informationen über QuidelOrtho Corp Unternehmen

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

QuidelOrtho Corp Informationen

BörsenkürzelQDEL
Name des UnternehmensQuidelOrtho Corp
IPO-datumFeb 01, 1991
CEOBlaser (Brian J)
Anzahl der mitarbeiter6600
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 01
Addresse9975 Summers Ridge Road
StadtSAN DIEGO
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl92121
Telefon18585521100
Websitehttps://www.quidelortho.com/
BörsenkürzelQDEL
IPO-datumFeb 01, 1991
CEOBlaser (Brian J)

Führungskräfte von QuidelOrtho Corp

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
104.41K
+9215.00%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
72.55K
+4929.00%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
39.40K
+5823.00%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
38.99K
+6959.00%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
25.14K
+13691.00%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
21.35K
+5650.00%
Ms. Ann D. Rhoads
Ms. Ann D. Rhoads
Independent Director
Independent Director
15.02K
+750.00%
Mr. John R. Chiminski
Mr. John R. Chiminski
Independent Director
Independent Director
2.52K
+2523.00%
Dr. Mary Lake Polan, M.D., Ph.D.
Dr. Mary Lake Polan, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Kenneth Jon (Ken) Widder, M.D.
Dr. Kenneth Jon (Ken) Widder, M.D.
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Kenneth F. Buechler, Ph.D.
Dr. Kenneth F. Buechler, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
104.41K
+9215.00%
Dr. Matthew W. Strobeck, Ph.D.
Dr. Matthew W. Strobeck, Ph.D.
Independent Director
Independent Director
72.55K
+4929.00%
Mr. Joseph M. Busky
Mr. Joseph M. Busky
Chief Financial Officer
Chief Financial Officer
39.40K
+5823.00%
Ms. Michelle A. Hodges, J.D.
Ms. Michelle A. Hodges, J.D.
Senior Vice President, Corporate Secretary, Chief Legal Officer
Senior Vice President, Corporate Secretary, Chief Legal Officer
38.99K
+6959.00%
Mr. Brian J. Blaser
Mr. Brian J. Blaser
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
25.14K
+13691.00%
Mr. Edward L. (Ed) Michael
Mr. Edward L. (Ed) Michael
Independent Director
Independent Director
21.35K
+5650.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Labs
373.80M
53.41%
Point-of-Care
164.60M
23.52%
Immunohematology
142.00M
20.29%
Donor Screening
14.70M
2.10%
Molecular Diagnostic Solutions
4.80M
0.69%
Nach RegionUSD
Name
Umsatz
Anteil
North America
381.40M
54.49%
Other
142.10M
20.30%
EMEA
91.80M
13.12%
China
84.60M
12.09%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Labs
373.80M
53.41%
Point-of-Care
164.60M
23.52%
Immunohematology
142.00M
20.29%
Donor Screening
14.70M
2.10%
Molecular Diagnostic Solutions
4.80M
0.69%

Aktionärsstatistik

Aktualisiert: Mon, Nov 17
Aktualisiert: Mon, Nov 17
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
T. Rowe Price Investment Management, Inc.
16.21%
BlackRock Institutional Trust Company, N.A.
13.72%
The Vanguard Group, Inc.
11.09%
Rubric Capital Management LP
6.83%
Fidelity Management & Research Company LLC
6.54%
Andere
45.61%
Aktionäre
Aktionäre
Anteil
T. Rowe Price Investment Management, Inc.
16.21%
BlackRock Institutional Trust Company, N.A.
13.72%
The Vanguard Group, Inc.
11.09%
Rubric Capital Management LP
6.83%
Fidelity Management & Research Company LLC
6.54%
Andere
45.61%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
68.40%
Investment Advisor/Hedge Fund
35.50%
Hedge Fund
14.78%
Research Firm
2.25%
Pension Fund
1.00%
Individual Investor
1.00%
Private Equity
0.71%
Bank and Trust
0.55%
Sovereign Wealth Fund
0.52%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
657
83.91M
123.52%
-20.38M
2025Q3
656
79.44M
116.95%
-23.17M
2025Q2
684
78.51M
115.63%
-21.42M
2025Q1
726
76.59M
113.26%
-21.60M
2024Q4
747
75.07M
111.30%
-13.02M
2024Q3
744
73.58M
109.44%
-4.02M
2024Q2
767
70.18M
104.79%
-7.57M
2024Q1
799
67.05M
100.24%
-5.28M
2023Q4
828
68.21M
102.09%
-2.95M
2023Q3
842
70.19M
105.17%
-4.01M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
T. Rowe Price Investment Management, Inc.
11.01M
16.21%
-124.03K
-1.11%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
9.32M
13.72%
+39.16K
+0.42%
Sep 30, 2025
The Vanguard Group, Inc.
7.60M
11.19%
-165.71K
-2.13%
Sep 30, 2025
Rubric Capital Management LP
4.64M
6.83%
--
--
Sep 30, 2025
Fidelity Management & Research Company LLC
4.44M
6.54%
+1.89M
+73.81%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.86M
4.21%
+350.64K
+13.98%
Sep 30, 2025
Newtyn Management, LLC
2.70M
3.97%
+994.33K
+58.30%
Sep 30, 2025
State Street Investment Management (US)
2.67M
3.93%
-32.20K
-1.19%
Sep 30, 2025
Invesco Advisers, Inc.
2.66M
3.92%
+1.33M
+100.02%
Sep 30, 2025
American Century Investment Management, Inc.
2.12M
3.11%
+199.91K
+10.44%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Tue, Dec 2
Aktualisiert: Tue, Dec 2
Name
Anteil
State Street SPDR S&P Health Care Equipment ETF
1.75%
Invesco S&P SmallCap Health Care ETF
1.12%
Ballast Small/Mid Cap ETF
0.94%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.56%
JPMorgan Fundamental Data Science Small Core ETF
0.35%
State Street SPDR S&P 600 Small Cap Value ETF
0.26%
Avantis US Small Cap Value ETF
0.26%
iShares S&P Small-Cap 600 Value ETF
0.25%
iShares U.S. Medical Devices ETF
0.22%
State Street SPDR S&P SmallCap 600 ESG ETF
0.19%
Mehr Anzeigen
State Street SPDR S&P Health Care Equipment ETF
Anteil1.75%
Invesco S&P SmallCap Health Care ETF
Anteil1.12%
Ballast Small/Mid Cap ETF
Anteil0.94%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil0.56%
JPMorgan Fundamental Data Science Small Core ETF
Anteil0.35%
State Street SPDR S&P 600 Small Cap Value ETF
Anteil0.26%
Avantis US Small Cap Value ETF
Anteil0.26%
iShares S&P Small-Cap 600 Value ETF
Anteil0.25%
iShares U.S. Medical Devices ETF
Anteil0.22%
State Street SPDR S&P SmallCap 600 ESG ETF
Anteil0.19%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI